Index | MSCI China All Shares Health Care 10/40 |
Investment focus | Equity, China, Health Care |
Fund size | GBP 2 m |
Total expense ratio | 0.65% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 23.10% |
Inception/ Listing Date | 14 January 2021 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | KraneShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | - |
Investment Advisor | |
Custodian Bank | - |
Revision Company | - |
Fiscal Year End | - |
Swiss representative | Waystone Fund Services (Switzeland) SA |
Swiss paying agent | Helvetische Bank AG |
Germany | Unknown |
Switzerland | Unknown |
Austria | Unknown |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Wuxi Biologics Cayman | 9.62% |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 6.79% |
BeiGene Ltd. | 4.66% |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 4.18% |
CSPC Pharmaceutical Group Ltd. | 4.05% |
Aier Eye Hospital Group Co., Ltd. | 3.62% |
WuXi AppTec Co., Ltd. | 3.56% |
Zhangzhou Pientzehuang | 3.00% |
Chongqing Zhifei | 2.41% |
Sino Biopharmaceutical Ltd. | 2.40% |
China | 89.88% |
Cayman Islands | 4.66% |
Hong Kong | 3.42% |
Other | 2.04% |
Health Care | 98.48% |
Industrials | 0.47% |
Other | 1.05% |
YTD | -13.37% |
1 month | +7.60% |
3 months | -1.62% |
6 months | -20.80% |
1 year | -25.66% |
3 years | -55.71% |
5 years | - |
Since inception (MAX) | -53.68% |
2023 | -21.97% |
2022 | -16.60% |
2021 | - |
2020 | - |
Volatility 1 year | 23.10% |
Volatility 3 years | 28.06% |
Volatility 5 years | - |
Return per risk 1 year | -1.11 |
Return per risk 3 years | -0.85 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -33.94% |
Maximum drawdown 3 years | -62.82% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -63.87% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
Borsa Italiana | EUR | KURE | - - | - - | - |
XETRA | EUR | KRUE | - - | - - | - |
London Stock Exchange | USD | KURE | KURE LN | FlowTraders |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Global X China Biotech UCITS ETF USD Accumulating | 0 | 0.68% p.a. | Accumulating | Full replication |